1. Home
  2. ASMB vs VBFC Comparison

ASMB vs VBFC Comparison

Compare ASMB & VBFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • VBFC
  • Stock Information
  • Founded
  • ASMB 2005
  • VBFC 1999
  • Country
  • ASMB United States
  • VBFC United States
  • Employees
  • ASMB N/A
  • VBFC N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • VBFC Major Banks
  • Sector
  • ASMB Health Care
  • VBFC Finance
  • Exchange
  • ASMB Nasdaq
  • VBFC Nasdaq
  • Market Cap
  • ASMB 97.8M
  • VBFC 116.5M
  • IPO Year
  • ASMB 2010
  • VBFC N/A
  • Fundamental
  • Price
  • ASMB $15.21
  • VBFC $80.91
  • Analyst Decision
  • ASMB Buy
  • VBFC
  • Analyst Count
  • ASMB 2
  • VBFC 0
  • Target Price
  • ASMB $35.00
  • VBFC N/A
  • AVG Volume (30 Days)
  • ASMB 42.2K
  • VBFC 1.4K
  • Earning Date
  • ASMB 11-07-2024
  • VBFC 01-23-2025
  • Dividend Yield
  • ASMB N/A
  • VBFC 0.89%
  • EPS Growth
  • ASMB N/A
  • VBFC 200.71
  • EPS
  • ASMB N/A
  • VBFC 4.84
  • Revenue
  • ASMB $28,326,000.00
  • VBFC $32,098,999.00
  • Revenue This Year
  • ASMB $282.16
  • VBFC N/A
  • Revenue Next Year
  • ASMB N/A
  • VBFC N/A
  • P/E Ratio
  • ASMB N/A
  • VBFC $16.73
  • Revenue Growth
  • ASMB N/A
  • VBFC 24.96
  • 52 Week Low
  • ASMB $9.12
  • VBFC $39.53
  • 52 Week High
  • ASMB $19.93
  • VBFC $80.91
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 46.95
  • VBFC 94.47
  • Support Level
  • ASMB $13.20
  • VBFC $77.47
  • Resistance Level
  • ASMB $16.75
  • VBFC $76.95
  • Average True Range (ATR)
  • ASMB 1.05
  • VBFC 0.23
  • MACD
  • ASMB -0.08
  • VBFC 0.09
  • Stochastic Oscillator
  • ASMB 53.03
  • VBFC 100.00

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About VBFC Village Bank and Trust Financial Corp.

Village Bank and Trust Financial Corp is a bank holding company. The banking is the primary operating business of the company. It offers a range of banking and related financial services, including checking, savings, certificates of deposit and other depository services, and commercial, real estate, and consumer loans, primarily in the Richmond, Virginia and Williamsburg, Virginia metropolitan areas. Its operating segment includes Commercial Banking and Mortgage Banking. The company generates maximum revenue from the Commercial Banking segment, which provides the mortgage banking segment with the short-term funds needed to originate mortgage loans through a warehouse line of credit and charges the mortgage banking segment interest based on the commercial banking segment's cost of funds.

Share on Social Networks: